Diagnostics & Research
The Diagnostics & Research industry has a total of 44 stocks, with a combined market cap of $879.85 billion, total revenue of $172.71 billion and a weighted average PE ratio of 48.64.
Market Cap
879.85B
Revenue
172.71B
Profits
18.09B
PE Ratio
48.64
Profit Margin
10.47%
Dividend Yield
0.19%
44 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 241.07B | -1.52% | 2,585,496 | 46.34B |
| 2 | DHR | Danaher Corporation | 152.87B | -0.47% | 5,293,223 | 25.11B |
| 3 | NTRA | Natera, Inc. | 56.33B | -1.21% | 2,443,276 | 2.71B |
| 4 | A | Agilent Technologies, Inc. | 47.41B | -0.54% | 2,718,197 | 7.37B |
| 5 | IQV | IQVIA Holdings Inc. | 42.61B | 0.30% | 988,409 | 16.98B |
| 6 | WAT | Waters Corporation | 42.16B | -1.57% | 1,043,897 | 4.64B |
| 7 | IDXX | IDEXX Laboratories, Inc. | 40.43B | 1.28% | 696,677 | 4.55B |
| 8 | ILMN | Illumina, Inc. | 39.95B | -1.19% | 3,169,784 | 4.49B |
| 9 | MTD | Mettler-Toledo International Inc. | 30.65B | -0.26% | 264,556 | 4.13B |
| 10 | LH | Labcorp Holdings Inc. | 25.48B | 0.71% | 703,729 | 14.35B |
| 11 | DGX | Quest Diagnostics Incorporated | 25.48B | 1.65% | 941,877 | 11.56B |
| 12 | GH | Guardant Health, Inc. | 22.22B | -1.65% | 1,599,423 | 1.18B |
| 13 | RVTY | Revvity, Inc. | 16.98B | -0.94% | 1,456,964 | 2.91B |
| 14 | MEDP | Medpace Holdings, Inc. | 16.82B | -0.26% | 223,106 | 2.78B |
| 15 | CRL | Charles River Laboratories International, Inc. | 14.23B | -0.77% | 1,176,902 | 4.00B |
| 16 | ICLR | ICON Public Limited Company | 12.69B | 0.26% | 1,026,195 | 8.29B |
| 17 | QGEN | Qiagen N.V. | 9.21B | -0.58% | 1,559,477 | 2.10B |
| 18 | GRAL | GRAIL, Inc. | 5.92B | -0.22% | 1,312,494 | 165.26M |
| 19 | RDNT | RadNet, Inc. | 5.37B | -0.58% | 722,262 | 2.27B |
| 20 | SHC | Sotera Health Company | 5.09B | -0.39% | 2,250,538 | 1.22B |
| 21 | BLLN | BillionToOne, Inc. | 4.50B | -0.36% | 386,304 | 397.41M |
| 22 | ADPT | Adaptive Biotechnologies Corporation | 4.16B | -0.72% | 2,646,924 | 308.08M |
| 23 | VCYT | Veracyte, Inc. | 3.51B | 1.02% | 1,221,821 | 561.90M |
| 24 | CDNA | CareDx, Inc. | 3.22B | -1.32% | 1,571,493 | 458.09M |
| 25 | NEO | NeoGenomics, Inc. | 2.06B | 0.31% | 3,518,271 | 766.30M |
| 26 | WGS | GeneDx Holdings Corp. | 2.02B | -1.17% | 734,791 | 454.43M |
| 27 | PSNL | Personalis, Inc. | 1.72B | 0.37% | 1,467,492 | 69.67M |
| 28 | FRNM | Freenome, Inc. | 1.70B | -1.37% | 948,162 | 35.41M |
| 29 | CSTL | Castle Biosciences, Inc. | 1.03B | 2.15% | 373,801 | 357.28M |
| 30 | OPK | OPKO Health, Inc. | 1.02B | -1.44% | 2,470,704 | 587.90M |
| 31 | FLGT | Fulgent Genetics, Inc. | 572.87M | 1.22% | 427,932 | 323.93M |
| 32 | MYGN | Myriad Genetics, Inc. | 401.73M | -1.87% | 2,259,576 | 806.60M |
| 33 | BDSX | Biodesix, Inc. | 270.43M | -2.99% | 95,953 | 102.94M |
| 34 | XGN | Exagen Inc. | 197.92M | -1.57% | 362,585 | 71.12M |
| 35 | BNR | Burning Rock Biotech Limited | 160.30M | 0.13% | 14,096 | 73.70M |
| 36 | QUCY | Quantum Cyber N.V. | 116.85M | -2.80% | 631,139 | 537.08K |
| 37 | IMDX | Insight Molecular Diagnostics Inc. | 107.34M | -5.20% | 227,317 | 1.67M |
| 38 | MDXH | MDxHealth SA | 55.39M | -3.22% | 60,898 | 114.02M |
| 39 | PRPO | Precipio, Inc. | 41.51M | -1.40% | 117,988 | 27.20M |
| 40 | ADVB | Advanced Biomed Inc. | 10.11M | -1.45% | 21,633 | - |
| 41 | NDRA | ENDRA Life Sciences Inc. | 8.89M | -2.15% | 12,997 | - |
| 42 | XWEL | XWELL, Inc. | 7.89M | 1.88% | 32,230 | 28.28M |
| 43 | BIAF | bioAffinity Technologies, Inc. | 3.04M | -8.44% | 35,253,385 | 5.90M |
| 44 | ISPC | iSpecimen Inc. | 2.75M | -0.91% | 71,252 | 466.30K |